Clinical trial Recruiting at 1 site Observational Ages 18 and up

Registry for patients with pancreatic diseases

Official title: Registry of Subjects Affected by Pancreatic Disease and Evaluated at the Pancreas Institute of Verona

Run by Azienda Ospedaliera Universitaria Integrata Verona · NCT03807687 · Data updated 2026-11-12

This study is collecting health information from people with pancreatic diseases to help improve understanding and treatment options for these conditions.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment3000 (estimated)
SponsorAzienda Ospedaliera Universitaria Integrata Verona
Academic / other
Locations1 site (Verona)
StatusRecruiting
StartedDecember 1, 2016
Main results expectedDecember 1, 2046
Study endsDecember 1, 2046
Registry record updatedJanuary 17, 2019
Trial IDNCT03807687 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are individuals diagnosed with any type of pancreatic disease, including both inflammatory and neoplastic conditions.

Probably not a fit

Patients who are physically or mentally unable to provide consent will not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical data registry collects comprehensive information about the health status and healthcare experiences of individuals affected by various pancreatic diseases, including both inflammatory and neoplastic conditions. The registry gathers a wide range of data, including demographic, clinical, biochemical, radiological, pharmacological, and genetic information, as well as audio and video recordings from surgical procedures. This data will be utilized for both prospective and retrospective studies to enhance understanding and treatment of pancreatic disorders.

Why it matters

Potential benefit: If successful, this registry could improve the understanding and management of pancreatic diseases, leading to better patient outcomes.

How similar studies have gone: While this registry approach is common in observational studies, the specific focus on pancreatic diseases may provide novel insights that have not been extensively explored in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* any type of pancreatic disease: inflammatory and neoplastic (including solid and cystic lesions)

Exclusion Criteria:

* physically or mentally inability to provide consent

Where it's running

  • AOUI Verona
    Verona, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.